Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty model. - Wikidata - awgldk - TriplyDB

Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty model.

Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty model.

http://www.wikidata.org/entity/Q37248454

about

A DAG-based comparison of interventional effect underestimation between composite endpoint and multi-state analysis in cardiovascular trials.A systematic comparison of recurrent event models for application to composite endpoints.

P2860

Q40135493-027B6A29-0FF4-4519-AB12-75DD8723307E Q47208736-C7AB298B-AEC2-46C6-B011-6375BBFCD718

P2860

Analysis of recurrent events with an associated informative dropout time: Application of the joint frailty model.

http://www.wikidata.org/entity/Q37248454

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Analysis of recurrent events w ...... on of the joint frailty model.

@en

Analysis of recurrent events w ...... on of the joint frailty model.

@nl

type

label

Analysis of recurrent events w ...... on of the joint frailty model.

@en

Analysis of recurrent events w ...... on of the joint frailty model.

@nl

prefLabel

Analysis of recurrent events w ...... on of the joint frailty model.

@en

Analysis of recurrent events w ...... on of the joint frailty model.

@nl

P1433

Q37248454-FC16A5B7-9333-402D-BFF6-1476C6F03F5A

P1476

Q37248454-047A2622-D44A-4A48-B7DF-98A7A52333BB

P2093

Q37248454-27B37A7D-E70B-4FBC-A6A8-07A3355A06E0

Q37248454-4612D460-F4C2-4DFC-8591-4A21BB1D2D0C

Q37248454-479DF4EF-2B58-4FD2-9B18-F3E156FD17F3

Q37248454-B40CADCF-4D30-48A3-9558-FB9CD7BE26CA

Q37248454-E4EA5449-83C5-4F4D-BDA0-71AD011A3021

P2860

Q37248454-0524DE27-1592-4A81-9984-9BCF087D260E

Q37248454-0977B669-54B2-4A1E-A48B-3862094C93C2

Q37248454-0A757239-234B-4203-BA8C-99F28B865717

Q37248454-1A2F3B9D-7A41-49DC-9733-97CA35D34369

Q37248454-31617E07-73AC-4159-A890-6E0F940C919D

Q37248454-5BF697D3-7951-4F39-A700-AE8FDD952C34

Q37248454-62F1EED1-35C7-427B-826E-0D39A244E86A

Q37248454-7EDFD0F3-5141-4DB6-9AA3-86E0E12CCED5

Q37248454-83C3C65E-5709-44FA-9FD2-1F96118B6985

Q37248454-94BF1082-0348-4D48-BF5E-C96B69432B19

P304

Q37248454-0635020E-B864-48F9-B357-D1EE066D51E9

P31

Q37248454-A8B3F3B8-E239-40F6-8E39-27B68FA6051D

P356

Q37248454-327BC887-37EB-4788-A410-6587B32B2E10

P407

Q37248454-01FEA287-1F79-4BF0-BFDF-5F4AEF1583BB

P433

Q37248454-A2CF2A2B-F99E-4105-BF89-38EC5D034A23

P478

Q37248454-98F37F8C-C374-4C79-8B15-13BD52D00B76

P577

Q37248454-CBDDC163-5C07-467D-AD0B-6E13B500A9EA

P5875

Q37248454-AB81BBA4-ED7C-4BE8-A3D3-0B6BBC0F83E4

P698

Q37248454-0B64E1EE-AAF3-4A77-B697-A0DDF99048C0

P932

Q37248454-E1462432-73AA-4A94-93E3-1C3BD7CEDF0B

P356

P1433

Statistics in Medicine

P1476

Analysis of recurrent events w ...... on of the joint frailty model.

@en

P2093

Alex Yaroshinsky

http://www.w3.org/2001/XMLSchema#string

David Stokar

http://www.w3.org/2001/XMLSchema#string

Janice Pogoda

http://www.w3.org/2001/XMLSchema#string

Jennifer K Rogers

http://www.w3.org/2001/XMLSchema#string

Stuart J Pocock

http://www.w3.org/2001/XMLSchema#string

P2860

The use of Gaussian quadrature for estimation in frailty proportional hazards models.

Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome?

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure.

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.

Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study.

Ways of measuring rates of recurrent events.

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved.

Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations.

P304

2195-2205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SIM.6853

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289988168

http://www.w3.org/2001/XMLSchema#string

P698

26751714

http://www.w3.org/2001/XMLSchema#string

P932

5019155

http://www.w3.org/2001/XMLSchema#string